1. Ford EB. Lie detection: historical, neuropsychiatric and legal dimensions. Int J Law Psychiatry. 2006;29(3):159-177.
2. Ohrn PG. Catecholamine infusion and gastrointestinal propulsion in the rat. Acta Chir Scand Suppl. 1979(461):43-52.
3. Sakamoto H. The study of catecholamine, acetylcholine and bradykinin in buccal circulation in dogs. Kurume Med J . 1979;26(2):153-162.
4. Bond CF Jr, Depaulo BM. Accuracy of deception judgments. Pers Soc Psychol Rev. 2006;10(3):214-234.
5. Vicianova M. Historical techniques of lie detection. Eur J sychology. 2015;11(3):522-534.
6. Matté JA. Forensic Psychophysiology Using the Polygraph: Scientific Truth Verification, Lie Detection. Williamsville, NY: JAM Publications; 2012.
7. Segrave K. Lie Detectors: A Social History. Jefferson, NC: McFarland & Company; 2004.
8. Nelson R. Scientific basis for polygraph testing. Polygraph. 2015;44(1):28-61.
9. Boucsein W. Electrodermal Activity . New York, NY: Springer Publishing; 2012.
10. US Congress, Office of Assessment and Technology. Scientific validity of polygraph testing: a research review and evaluation. https://ota.fas.org/reports/8320.pdf. Published 1983. Accessed June 12, 2019.
11. United States v Scheffer, 523 US 303 (1998).
12. United States v Piccinonna, 729 F Supp 1336 (SD Fl 1990).
13. Fridman DS, Janoe JS. The state of judicial gatekeeping in New Mexico. https://cyber.harvard.edu/daubert/nm.htm. Updated April 17, 1999. Accessed May 20, 2019.
14. Gibbons CH. Small fiber neuropathies. Continuum (Minneap Minn) . 2014;20(5 Peripheral Nervous System Disorders):1398-1412.
15. US Department of Defense. Directive 5210.48: Credibility assessment (CA) program. https://fas.org/irp/doddir/dod/d5210_48.pdf. Updated February 12, 2018. Accessed May 30, 2019.
16. Postuma RB, Gagnon JF, Pelletier A, Montplaisir J. Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord. 2013;28(5):597-604.
17. Adlan AM, Lip GY, Paton JF, Kitas GD, Fisher JP. Autonomic function and rheumatoid arthritis: a systematic review. Semin Arthritis Rheum . 2014;44(3):283-304.
18. Di Ciaula A, Grattagliano I, Portincasa P. Chronic alcoholics retain dyspeptic symptoms, pan-enteric dysmotility, and autonomic neuropathy before and after abstinence. J Dig Dis. 2016;17(11):735-746.
19. Thaung HA, Baldi JC, Wang H, et al. Increased efferent cardiac sympathetic nerve activity and defective intrinsic heart rate regulation in type 2 diabetes. Diabetes. 2015;64(8):2944-2956.
20. US Department of Defense, Office of the Undersecretary of Defense for Intelligence. Department of Defense polygraph program process and compliance study: study report. https://fas.org/sgp/othergov/polygraph/dod-poly.pdf. Published December 19, 2011. Accessed May 20, 2019.
21. Ladage D, Schwinger RH, Brixius K. Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity. Cardiovasc Ther. 2013;31(2):76-83.
22. D’Souza RS, Mercogliano C, Ojukwu E, et al. Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis Emerg Med J. 2018;35:325-331.
23. Gheorghiev MD, Hosseini F, Moran J, Cooper CE. Effects of pseudoephedrine on parameters affecting exercise performance: a meta-analysis. Sports Med Open. 2018;4(1):44.
24. Frellick M. Top-selling, top-prescribed drugs for 2016. https://www.medscape.com/viewarticle/886404. Published October 2, 2017. Accessed May 20, 2019.
25. Lall DM, Dutschmann M, Deuchars J, Deuchars S. The anti-malarial drug mefloquine disrupts central autonomic and respiratory control in the working heart brainstem preparation of the rat. J Biomed Sci. 2012;19:103.
26. Ritchie EC, Block J, Nevin RL. Psychiatric side effects of mefloquine: applications to forensic psychiatry. J Am Acad Psychiatry Law. 2013;41(2):224-235.
27. Belliveau JW, Kennedy DN Jr, McKinstry RC, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science. 1991;254(5032):716-719.
28. Ito A, Abe N, Fujii T, et al. The contribution of the dorsolateral prefrontal cortex to the preparation for deception and truth-telling. Brain Res. 2012;1464:43-52.
29. Langleben DD, Hakun JG, Seelig D. Polygraphy and functional magnetic resonance imaging in lie detection: a controlled blind comparison using the concealed information test. J Clin Psychiatry. 2016;77(10):1372-1380.
30. Boire RG. Searching the brain: the Fourth Amendment implications of brain-based deception detection devices. Am J Bioeth. 2005;5(2):62-63; discussion W5.
31. Langleben DD. Detection of deception with fMRI: Are we there yet? Legal Criminological Psychol. 2008;13(1):1-9.
32. Marcuse LV, Fields MC, Yoo J. Rowans Primer of EEG . 2nd ed. Edinburgh, Scotland, United Kingdom: Elsevier; 2016.
33. Farwell LA, Donchin E. The truth will out: interrogative polygraphy (“lie detection”) with event-related brain potentials. Psychophysiology. 1991;28(5):531-547.
34. Sur S, Sinha VK. Event-related potential: an overview. Ind Psychiatry J. 2009;18(1):70-73.
35. Polich J. Updating P300: an integrative theory of P3a and P3b. Clinical Neurophysiol. 2007;118(10):2128-2148.
36. Mertens R, Allen, JJB. The role of psychophysiology in forensic assessments: Deception detection, ERPs, and virtual reality mock crime scenarios. Psychophysiology. 2008;45(2):286-298.
37. Rosenfeld JP, Labkovsky E. New P300-based protocol to detect concealed information: resistance to mental countermeasures against only half the irrelevant stimuli and a possible ERP indicator of countermeasures. Psychophysiology. 2010;47(6):1002-1010.
38. Farwell LA, Smith SS. Using brain MERMER testing to detect knowledge despite efforts to conceal. J Forensic Sci. 2001;46(1):135-143.